Proteomic Analysis of Bladder Cancer Biomarkers

Bryan, Rik (Principal Investigator)
Ward, Douglas (Co-Investigator)

Cancer and Genomic Sciences

Short title	Proteomic Analysis of Bladder Cancer Biomarkers
Status	Finished
Effective start/end date	1/05/10 → 30/09/10

Funding

UHB CHARITABLE FUNDS

2 Article
1 Patent

Exploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratification
Snell, K., Ward, D., Gordon, N., Goldsmith, J., Sutton, A., Patel, P., James, N., Zeegers, M., Cheng, K. & Bryan, R., 18 May 2018, In: OncoTarget. 9, 38, p. 25244-25253 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
9 Citations (Scopus)

187 Downloads (Pure)
A systematic review of the diagnostic and prognostic value of urinary protein biomarkers in urothelial bladder cancer
D'Costa, J., Goldsmith, J., Wilson, J., Bryan, R. & Ward, D., 27 Jul 2016, In: Bladder Cancer. 2, 3, p. 301-317
Research output: Contribution to journal › Article › peer-review

Open Access
File
55 Citations (Scopus)

355 Downloads (Pure)
Bladder cancer prognosis
Bryan, R. (Inventor) & Ward, D. (Inventor), 2 Jun 2016, IPC No. G01N 33/574 (2006.01), G01N 33/68 (2006.01), Patent No. WO/2016/083832, Priority date 28 Nov 2014, Priority No. US 62/085,433
Research output: Patent

Open Access
File
4 Citations (Scopus)

97 Downloads (Pure)